ArticleFrontiers in oncology2023

Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience.

Enikő Sebestyén et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.